At the news
? BEARISHIMPACT 5/10 144 filed Aug 11, 2026 at 12:52 ET
Cambrian BioPharma Inc, a 10% stockholder of Faeth Therapeutics, filed a Form 144 notice of intent to sell 130,142 shares of common stock, with an estimated aggregate market value of approximately $3.64 million. The shares were acquired in a private placement in January 2020. This represents a notable insider selling signal from a major shareholder, though the sale is not yet executed and the filing is an advance notice of intent.
- Cambrian BioPharma Inc, a 10% stockholder, filed a Form 144 to sell 130,142 shares of Faeth Therapeutics common stock.
- The estimated aggregate market value of the proposed sale is approximately $3.64 million based on a 07/22/2026 trade date.
- Shares were acquired in a private placement on 01/10/2020.
- The filing date is 08/11/2026, and the sale is planned through Fidelity Brokerage Services LLC.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access